Gene Therapy in DR and neovascular AMD: past, present, and future
This online course provides an up-to-date overview of gene therapy for diabetic retinopathy (DR) and neovascular age-related macular degeneration (nAMD). Through expert-led presentations and interactive discussion, participants will explore the scientific rationale, current evidence, patient selection, delivery methods, safety considerations, and future perspectives of gene therapy, gaining practical insights into one of the most promising frontiers in retinal disease management.
ESASO Scientific Director: Mario Romano
Course Scientific Coordinator: Giuseppe Querques and Riccardo Sacconi
Teaching language: English 
Next Course in 2027 
⭐⭐⭐⭐⭐ More than 1700 students
What you'll learn
✔️
Understand the scientific principles and mechanisms of gene therapy in retinal diseases
✔️
Review the latest evidence on gene therapy for diabetic retinopathy and neovascular AMD
✔️
Identify suitable patient profiles and evaluate current delivery strategies and safety considerations
✔️
Explore the future role of gene therapy and its potential integration into clinical retina practice
Skills you'll acquire
Gene therapy fundamentals
Patient selection for gene therapy
Management of retinal diseases
Interpretation of emerging clinical evidence
FREE
Take me to the registration form
Date: 18 November 2026
Time: 17.30 - 19.30 CEST
Venue: Live on eLOS
This course includes:
2 educational hours
International, experienced Faculty
Downloadable resources
eLOS account
Assistance of Event Manager
Accreditation Certificate
ESASO Certificate of Attendance
Swiss-level organisation
Course sponsor
with the unrestricted financial support from 
Course Programme
Loading Viewer...